DuPont Delivers Strong Earnings Growth in Third Quarter 2007
WILMINGTON, Del., Oct. 23, 2007 -- Highlights
-- Third quarter 2007 earnings per share were $0.56 versus $0.52 in the
third quarter 2006. Excluding significant items, earnings per share
increased 20 percent to $0.59 in the current quarter from $0.49 in the
third quarter 2006.
-- Sales rose 6 percent to $6.7 billion. Excluding portfolio changes,
sales grew 7 percent, reflecting 3 percent volume growth, 2 percent
higher local selling prices and 2 percent currency benefit.
-- Strong revenue growth in all segments outside the United States more
than offset lower U.S. demand.
-- Fixed costs as a percentage of sales improved 90 basis points from the
prior-year quarter.
-- Segment pre-tax operating income margin increased to 14.2 percent from
13.3 percent in the prior-year quarter, excluding significant items.
-- DuPont
now expects full year 2007 earnings to be $3.15 to
$3.20 per share versus its previous outlook of about $3.15 per share,
excluding significant items.
"DuPont generated solid operating leverage and 20 percent earnings per share growth in the third quarter," said Charles O. Holliday, Jr., DuPont chairman and chief executive officer. "We increased sales outside the United States 11 percent and grew worldwide Agriculture & Nutrition segment sales 21 percent. Our performance reflects the concentrated actions of our employees to execute our growth strategies and productivity initiatives, which overcame the challenges of higher cost ingredients and lower U.S. demand."
Global Consolidated Sales
Consolidated net sales increased 6 percent to $6.7 billion in the quarter. Excluding portfolio changes, sales grew 7 percent and sales generated outside the United States were 64 percent of total consolidated net sales. Volume rose 6 percent outside the United States, with significant growth in Latin America, led by the Agriculture & Nutrition segment. A summary of third quarter 2007 worldwide and regional sales performance, excluding portfolio changes, is shown in the table below.
Three Months Ended
September 30, 2007 Percentage Change Due to:
Local Currency
(Dollars in billions) $ % Change* Currency Effect Volume*
Price
U.S. $2.4 (1)% 1 - (2)
Europe 1.9 11 2 6 3
Asia Pacific 1.3 7 1 2 4
Canada & Latin America 1.1 22 3 3 16
Total Consolidated Sales $6.7 7% 2 2 3
*Excludes portfolio changes
Net Income and Earnings Per Share
Net income for the third quarter 2007 was $526 million, or $0.56 per share, including a $0.03 per share litigation charge. Third quarter 2006 net income was $485 million, or $0.52 per share, including a $0.03 per share benefit for insurance recoveries.
The table below shows the variances in third quarter 2007 earnings per share (EPS) versus third quarter 2006:
EPS Analysis
EPS
3rd Quarter 2006 $.52
Insurance recoveries (.03)
3rd Quarter 2006 EPS excluding significant items .49
Local prices .09
Variable costs* (.12)
Volume .04
Fixed costs* (.03)
Currency .05
Pharmaceuticals .02
Exchange Gain & Interest Expense .02
Tax .00
Other .03
3rd Quarter 2007 EPS excluding significant items .59
Litigation Reserve (.03)
3rd Quarter 2007 $.56
* Excludes volume and currency impact
The $0.03 per share variance in fixed costs, noted above, includes about $0.04 per share from growth investments to accelerate biotech research and development, expand global sales coverage in seeds, and increase future production capacity, partially offset by a $0.01 per share benefit from cost reduction projects in excess of inflation. The $0.03 per share variance in other, noted above, is principally related to a benefit of $0.02 in the Agriculture & Nutrition segment resulting from a contract termination payment received in 2007.
Business Segment Performance
Segment pre-tax operating income (PTOI) for the third quarter 2007 grew 2 percent to $916 million from $900 million in the third quarter 2006. Excluding significant items from the prior-year third quarter, segment PTOI increased 12 percent from $850 million.
Segment sales (excluding portfolio changes), PTOI, and related variances versus the third quarter 2006 are shown in the following tables:
SEGMENT SALES* Three Months Ended Percentage Change
(Dollars in billions) September 30, 2007 Due to:
USD
$ % Change** Price Volume**
Agriculture & Nutrition 1.1 21 10 11
Coatings & Color Technologies 1.6 3 3 -
Electronic & Communication
Technologies 0.9 5 - 5
Performance Materials 1.7 5 7 (2)
Safety & Protection 1.4 6 2 4
* Segment sales include transfers
** Excludes portfolio changes
PRE-TAX OPERATING INCOME
(Dollars in millions) Three Months Ended September 30
2007 2006 % Change
vs. 2006
Agriculture & Nutrition $(96) $(154) 38 %
Coatings & Color Technologies* 204 281 (27)
Electronic & Communication
Technologies 138 132 5
Performance Materials 196 169 16
Pharmaceuticals 237 210 13
Safety & Protection* 313 293 7
Other* (76) (31) n.m.
$916 $900 2 %
* See Schedule B for significant items
Agriculture & Nutrition
-- Sales grew 21 percent to $1.1 billion due to strong performance in
international seeds. Volume grew 11 percent and USD selling prices
increased 10 percent. Significant global gains in seed corn, soybeans
and canola, as well as strong fungicide sales in Latin America and
Europe, more than offset weak chemical sales in North America.
-- PTOI improved 38 percent to a seasonal loss of $96 million. Excluding
$25 million of income resulting from a contract termination payment
received in 2007, PTOI improved 21 percent with strong sales in Latin
America and Europe and restructuring benefits offset by reinvestments
in the company's seed business.
Coatings & Color Technologies
-- Sales increased 2 percent to $1.6 billion. Excluding the impact of a
divested business, sales grew 3 percent. Titanium dioxide and coatings
sales growth in Asia Pacific and Latin America was largely offset by
continued weak U.S. markets.
-- PTOI was $204 million, compared with $281 million in the prior-year
quarter. Excluding a $43 million insurance recovery in the prior year,
PTOI declined 14 percent. Improved earnings in automotive OEM coatings
were more than offset by lower sales into the U.S. markets.
Electronic & Communication Technologies
-- Sales grew 5 percent to $935 million primarily due to volume growth in
fluoroproducts and packaging graphics and pass-through of higher metals
prices. Demand for electronic materials, particularly for the cell
phone and semiconductor supply chains, improved in the latter part of
the quarter.
-- PTOI increased 5 percent to $138 million reflecting revenue growth and
fixed cost control, partially offset by higher variable costs. Earnings
growth was led by packaging graphics.
Performance Materials
-- Sales grew 6 percent to $1.7 billion. Excluding a portfolio change,
sales grew 5 percent primarily due to higher USD selling prices. These
gains were partially offset by lower volume, principally related to the
automotive market, effects of Hurricane Humberto at the company's
Orange, Texas, facility and ingredient supply constraints. Sales were
strong in Europe and Latin America.
-- PTOI increased 16 percent to $196 million reflecting broad-based
strength across the segment's primary product lines.
Safety & Protection
-- Sales grew 2 percent to $1.4 billion. Excluding a portfolio change,
sales grew 6 percent reflecting strong sales in the Kevlar(R),
Nomex(R), Tyvek(R) and specialty chemical products in spite of a weak
U.S. residential housing market.
-- PTOI was $313 million, compared to $293 million in the prior-year
quarter. Excluding a $7 million insurance recovery in the prior year,
PTOI increased 9 percent reflecting the strength in Kevlar(R) and
Nomex(R) product lines and solid demand for Tyvek(R) in multiple
markets.
Additional information on segment performance is available on the DuPont Investor Center website at www.dupont.com.
Share Repurchase Program Update
In the third quarter 2007, the company repurchased 22.9 million shares of its stock for $1.1 billion as the final step in completing the $5 billion share repurchase program announced in October 2005. Under this program, the company repurchased 112.8 million shares, or about 11 percent of the diluted shares outstanding in October 2005.
Outlook
DuPont updated its outlook for full-year 2007 earnings per share from about $3.15 to a range of $3.15 to $3.20, excluding the $0.09 per share charge for significant items in the year-to-date results. For the fourth quarter 2007, the company expects strong sales growth outside the United States will continue to exceed the effect of lower demand from U.S. housing and auto markets. The company anticipates PTOI to grow substantially from last year's fourth quarter, reflecting continued execution of its growth strategies and productivity initiatives partially offset by higher ingredient costs. Net income growth is expected to be tempered by a much higher base tax rate in the fourth quarter versus the prior year.
DuPont's 2008 outlook is positive. The company expects strong revenue growth in emerging markets and anticipates significant earnings growth in its Agriculture & Nutrition segment. New product acceleration efforts and continued cost and capital productivity gains across the company are expected to be additional contributing factors. This positive outlook is moderated by potentially lower demand from U.S. housing and automotive markets and the uncertainty of ingredient costs. The company's current outlook is to grow 2008 earnings per share about 5 to 10 percent from its anticipated 2007 earnings of $3.15 to $3.20 per share before significant items.
The company generated 11 percent earnings per share growth before significant items in the first nine months of the year.
"This performance places us firmly on track to achieve our 2007 outlook and sets the stage for continued growth in 2008," Holliday said. "While uncertainties remain in the global economy, we are confident in our ability to deliver solid earnings growth next year.
"Looking beyond 2008, DuPont is well-positioned to capitalize on exciting growth opportunities in markets such as energy efficiency, agriculture productivity, renewable energy, and safety and security," Holliday said. "We have aligned our research and development investments with these growth opportunities and are positioned to deliver attractive returns in these fast growing markets with a strong pipeline of new technologies and products."
Use of Non-GAAP Measures
Management believes that measures of income excluding significant items ("non-GAAP" information) are meaningful to investors because they provide insight with respect to ongoing operating results of the company. Such measurements are not recognized in accordance with generally accepted accounting principles (GAAP) and should not be viewed as an alternative to GAAP measures of performance. Reconciliations of non-GAAP measures to GAAP are provided in Schedule D.
DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.
Forward-Looking Statements: This news release contains forward-looking statements based on management's current expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects," "anticipates," "plans," "intends," "projects," "indicates," and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in documents filed with the Securities and Exchange Commission by DuPont, particularly its latest annual report on Form 10-K and quarterly report on Form 10-Q, as well as others, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of countries in which the company does business; competitive pressures; successful integration of structural changes, including restructuring plans, acquisitions, divestitures and alliances; cost of raw materials, research and development of new products, including regulatory approval and market acceptance; seasonality of sales of agricultural products; and severe weather events that cause business interruptions, including plant and power outages, or disruptions in supplier and customer operations.
E. I. du Pont de Nemours and Company
Consolidated Income Statements
(Dollars in millions, except per share amounts)
SCHEDULE A
Three Months Ended Nine Months Ended
September 30, September 30,
2007 2006 2007 2006
Net sales $6,675 $6,309 $22,395 $21,145
Other income, net (a) 365 336 1,045 1,002
Total 7,040 6,645 23,440 22,147
Cost of goods sold and
other operating
charges (b),(c),
(d),(e) 5,115 4,762 16,216 15,326
Selling, general and
administrative expenses 797 756 2,512 2,400
Amortization of
intangible assets 53 57 163 172
Research and
development expense 332 320 979 961
Interest expense 113 114 320 347
Total 6,410 6,009 20,190 19,206
Income before income
taxes and minority
interests 630 636 3,250 2,941
Provision for income
taxes (a) 102 151 802 661
Minority interests in
earnings of consolidated
subsidiaries 2 - 5 3
Net income $526 $485 $2,443 $2,277
Basic earnings per
share of common stock $0.57 $0.52 $2.64 $2.46
Diluted earnings per
share of common stock $0.56 $0.52 $2.61 $2.44
Dividends per share of
common stock $0.37 $0.37 $1.11 $1.11
Average number of
shares outstanding used
in earnings per share
(EPS) calculation:
Basic 921,105,750 922,023,399 922,957,576 921,620,506
Diluted 929,316,177 927,231,880 931,774,150 928,809,510
(a), (b), (c), (d), (e) See Notes to Schedules of Significant Items for
additional information.
E. I. du Pont de Nemours and Company
Schedules of Significant Items
(Dollars in millions, except per share amounts)
SCHEDULE B
SIGNIFICANT ITEMS
Pre-tax After-tax ($ Per Share)
2007 2006 2007 2006 2007 2006
1st Quarter - Total $(52) $(128) $(52) $(50) $(0.06) $(0.05)
2nd Quarter - Total $- $- $- $31 $- $0.03
3rd Quarter:
Litigation related item (b) (40) - (26) - (0.03) -
Insurance recoveries (d) - 50 - 33 - 0.03
3rd Quarter - Total $(40) $50 $(26) $33 $(0.03) $0.03
Year-to-date - Total $(92) $(78) $(78) $14 $(0.09) $0.01
SIGNIFICANT ITEMS BY SEGMENT
Three Months Ended Nine Months Ended
September 30, September 30,
2007 2006 2007 2006
Agriculture & Nutrition $- $- $- $-
Coatings & Color Technologies (d),
(e) - 43 - (92)
Electronic & Communication
Technologies - - - -
Performance Materials (c) - - (52) -
Safety & Protection (d) - 7 - 7
Textiles & Interiors - - - -
Other (b) (40) - (40) -
Total (excluding Corporate) $(40) $50 $(92) $(85)
(b), (c), (d), (e) See Notes to Schedules of Significant Items for
additional information.
E. I. du Pont de Nemours and Company
Notes to Schedules of Significant Items
(Dollars in millions, except per share amounts)
(a) Year-to-date 2006 includes benefits for the reversal of accrued
interest of $7 ($4 after-tax) in Other income, net and the reversal of
$44 of income taxes associated with favorable settlement of certain
prior-year tax contingencies which had been previously reserved.
Year-to-date 2006 also includes a tax benefit of $31 associated with
an increase in the deferred tax assets of a European subsidiary for a
tax basis investment loss recognized on the local tax return.
(b) Third quarter and year-to-date 2007 includes a $40 charge in Cost of
goods sold and other operating charges for existing litigation in the
Other segment relating to a discontinued business.
(c) Year-to-date 2007 also includes a net $52 charge in Cost of goods sold
and other operating charges for existing litigation in the Performance
Materials segment in connection with the elastomers antitrust matter.
(d) Third quarter and year-to-date 2006 includes a $50 benefit in Cost of
goods sold and other operating charges resulting from initial
insurance recoveries relating to the damage suffered from Hurricane
Katrina in 2005. Pretax amounts by segment were: $43 - Coatings &
Color Technologies and $7 - Safety & Protection.
(e) Year-to-date 2006 includes a restructuring charge of $135 in the
Coatings & Color Technologies segment in connection with the company's
plans to close and consolidate certain manufacturing and laboratory
sites. Cost of goods sold and other operating charges includes
employee separation charges, primarily in Europe and the U.S., for
approximately 1,300 employees and other exit costs.
E. I. du Pont de Nemours and Company
Consolidated Segment Information
(Dollars in millions)
SCHEDULE C
Three Months Ended Nine Months Ended
September 30, September 30,
SEGMENT SALES (1) 2007 2006(2) 2007 2006(2)
Agriculture & Nutrition $1,067 $885 $5,591 $4,994
Coatings & Color Technologies 1,649 1,612 4,909 4,715
Electronic & Communication
Technologies 935 892 2,834 2,719
Performance Materials 1,651 1,559 4,919 4,656
Safety & Protection 1,408 1,385 4,244 4,158
Other 43 47 136 141
Total Segment sales $6,753 $6,380 $22,633 $21,383
Elimination of transfers (78) (71) (238) (238)
Consolidated net sales $6,675 $6,309 $22,395 $21,145
Three Months Ended Nine Months Ended
September 30, September 30,
PRETAX OPERATING INCOME/(LOSS)
(PTOI) (3) 2007 2006(2) 2007 2006(2)
Agriculture & Nutrition $(96) $(154) $983 $873
Coatings & Color Technologies 204 281 624 530
Electronic & Communication
Technologies 138 132 438 460
Performance Materials 196 169 573 515
Pharmaceuticals 237 210 703 579
Safety & Protection 313 293 922 869
Other (76) (31) (169) (119)
Total Segment PTOI $916 $900 $4,074 $3,707
Exchange (losses) and gains (4) (30) (3) (50) 5
Corporate expenses & net interest (256) (261) (774) (771)
Income before income taxes and
minority interests $630 $636 $3,250 $2,941
(1) Sales for the reporting segments include transfers.
(2) Certain reclassifications of 2006 segment data have been made to
reflect changes in organizational structure for 2007.
(3) Refer to the Notes to Schedules of Significant Items for additional
information.
(4) Net after-tax exchange activity for the three and nine months ended
September 30, 2007 was a gain of $8 and a loss of $17, respectively.
For the three and nine months ended September 30, 2006, the net
after-tax exchange activity were losses of $7 and $19, respectively.
Gains and losses resulting from the company's hedging program are
largely offset by associated tax effects.
E. I. du Pont de Nemours and Company
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)
SCHEDULE D
Summary of Earnings Comparisons
Three Months Ended
September 30,
%
2007 2006 Change
Segment PTOI $916 $900 2%
Significant Items (benefit)/
charge included in PTOI
(per Schedule B) 40 (50)
Segment PTOI excluding
Significant Items $956 $850 12%
Net Income $526 $485 8%
Significant Items (benefit)/
charge included in Net Income
(per Schedule B) 26 (33)
Net Income excluding
Significant Items $552 $452 22%
EPS $0.56 $0.52 8%
Significant Items (benefit)/
charge included in EPS
(per Schedule B) 0.03 (0.03)
EPS excluding
Significant Items $0.59 $0.49 20%
Average number of diluted
shares outstanding 929,316,177 927,231,880 0.2%
Nine Months Ended
September 30,
%
2007 2006 Change
Segment PTOI $4,074 $3,707 10%
Significant Items (benefit)/
charge included in PTOI
(per Schedule B) 92 85
Segment PTOI excluding
Significant Items $4,166 $3,792 10%
Net Income $2,443 $2,277 7%
Significant Items (benefit)/
charge included in Net Income
(per Schedule B) 78 (14)
Net Income excluding
Significant Items $2,521 $2,263 11%
EPS $2.61 $2.44 7%
Significant Items (benefit)/
charge included in EPS
(per Schedule B) 0.09 (0.01)
EPS excluding
Significant Items $2.70 $2.43 11%
Average number of diluted
shares outstanding 931,774,150 928,809,510 0.3%
Calculation of Segment PTOI as a Percent of Segment Sales
Three Months Ended Nine Months Ended
September 30, September 30,
% %
2007 2006 Change 2007 2006 Change
Segment PTOI excluding
Significant Items $956 $850 12% $4,166 $3,792 10%
Segment sales $6,753 $6,380 6% $22,633 $21,383 6%
Segment PTOI as a percent
of segment sales 14.2% 13.3% 18.4% 17.7%
E. I. du Pont de Nemours and Company
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)
SCHEDULE D (continued)
Reconciliations of Adjusted EBIT / Adjusted EBITDA to Consolidated
Income Statement
Three Months Ended Nine Months Ended
September 30, September 30,
2007 2006 2007 2006
Income before income taxes and
minority interests $630 $636 $3,250 $2,941
Less: Minority interest in
earnings of consolidated
subsidiaries (1) (3) (1) (7) (4)
Add: Net interest expense (2) 104 108 292 312
Adjusted EBIT 731 743 3,535 3,249
Add: Depreciation and
amortization (3) 331 343 1,003 1,014
Adjusted EBITDA $1,062 $1,086 $4,538 $4,263
(1) Excludes income taxes.
(2) Includes interest expense plus amortization of capitalized interest
less interest income.
(3) Excludes amortization of capitalized interest.
Reconciliations of Fixed Costs as a Percent of Sales
Three Months Ended Nine Months Ended
September 30, September 30,
2007 2006 2007 2006
Total charges and expenses -
consolidated income statements $6,410 $6,009 $20,190 $19,206
Remove:
Interest expense (113) (114) (320) (347)
Variable costs (1) (3,332) (3,124) (10,856) (10,066)
Significant Items -
benefit/(charge) (2) (40) 50 (92) (85)
Fixed costs $2,925 $2,821 $8,922 $8,708
Consolidated net sales $6,675 $6,309 $22,395 $21,145
Fixed costs as a percent of sales 43.8% 44.7% 39.8% 41.2%
(1) Includes variable manufacturing costs, freight, commissions and other
selling expenses which vary with the volume of sales.
(2) See Schedule B for detail of Significant Items.
E. I. du Pont de Nemours and Company
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)
SCHEDULE D (continued)
Year Ended
December 31,
2006
2007 Outlook Actual
Earnings per share - excluding
Significant Items $3.15 to $3.20 $2.88
Significant Items included in EPS:
Litigation related charges - Other (0.03) -
Litigation related charges -
Performance Materials (0.06) -
Restructuring charges -
Agriculture & Nutrition - (0.13)
Coatings & Color Technologies - (0.10)
American Jobs Creation Act - 0.02
Hurricane related items - 0.10
Asbestos insurance recovery - 0.04
Asset impairment - Safety & Protection - (0.03)
Sales terms and expense accrual changes - (0.04)
Corporate tax-related items - 0.64
Net (charge)/benefit for
Significant Items (0.09) 0.50
Reported EPS $3.06 to $3.11 $3.38
Reconciliation of Base Income Tax Rate to Effective Income Tax Rate
Three Months Ended Nine Months Ended
September 30, September 30,
2007 2006 2007 2006
Income before income taxes and
minority interests $630 $636 $3,250 $2,941
Add: Significant Items -
(benefit)/charge 40 (50) 92 78
Net exchange losses
/ (gains) 30 3 50 (5)
Income before income taxes,
Significant Items, exchange
gains/losses and
minority interests $700 $589 $3,392 $3,014
Provision for income taxes $102 $151 $802 $661
Add: Tax (expense)/benefit on
Significant Items 14 (17) 14 92
Tax benefit/(expense)
on exchange gains/losses 38 (4) 33 (24)
Provision for income taxes,
excluding taxes on Significant
Items and exchange gains $154 $130 $849 $729
Effective income tax rate 16.2% 23.7% 24.7% 22.5%
Base income tax rate 22.0% 22.1% 25.0% 24.2%
E. I. du Pont de Nemours and Company
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)
SCHEDULE D (continued)
Reconciliation of Base Income Tax Rate to Effective Income Tax Rate
"Reconciliation of Percentage Change in Sales to Percentage Change in
Sales Excluding Portfolio Changes for Three Months Ended September 30,
2007"
Change in
Less: Consolidated Sales
Change in Portfolio Excluding
Consolidated Sales Changes(1) Portfolio Changes
U.S. (2)% (1)% (1)%
Europe 9 (2) 11
Asia Pacific 5 (2) 7
Canada & Latin America 22 - 22
Total Consolidated Sales 6% (1)% 7%
Less: Change in Segment
Change in Segment Portfolio Sales Excluding
Sales Changes(1) Portfolio Changes
Agriculture & Nutrition 21% -% 21%
Coatings & Color Technologies 2 (1) 3
Electronic & Communication
Technologies 5 - 5
Performance Materials 6 1 5
Safety & Protection 2% (4)% 6%
(1) Portfolio changes are historically included in percentage changes
due to volume.